🔎 Trials Near Me

Gara Jalqabaatti › Kansa Mataa fi Morma

Qorannoo klinikaalii Kansa Mataa fi Morma Ameerikaa Keessatti hirmaatuu

Qorannoo 147 Kansa Mataa fi Morma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Using Silverlon® for Head and Neck Patients With Tracheostomies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07856732

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06303180

Biospecimen Procurement for Head and Neck Disorders

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03429036

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06788990

Distance-Based Exercise to Preserve Function and Prevent Disability

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06997068

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07090499

Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07848841

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07085091

DESTINY-PANTUMOUR04

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06667427

Intratumoral N17350 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07339176

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06736379

Continuous Monitoring of Microvascular Anastomoses: An Observational Trial

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07823283

A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07644585

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06607406

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07020117

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06096038

Effects of Infusion Timing on Treatment Response in Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07630168

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06633224

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.